Table 6.
Excess relative risk (ERR) and excess absolute risk (EAR) for five patients
| Organ | Modality\ID |
ERR (EAR*) |
||||
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | ||
|
Thyroid |
IMRT |
0.11 |
0.05 |
0.15 |
0.58 |
0.18 |
| VMAT |
0.08 |
0.05 |
0.12 |
0.49 |
0.18 |
|
| TOMO |
0.10 |
0.08 |
0.10 |
0.42 |
0.12 |
|
|
Lung |
IMRT |
0.03 (1.47) |
0.02 (0.50) |
0.04 (1.76) |
2.98 (18.22) |
0.34 (1.01) |
| VMAT |
0.07 (1.51) |
0.02 (0.53) |
0.04 (1.95) |
3.31 (22.20) |
0.42 (1.26) |
|
| TOMO |
0.91 (20.08) |
0.39 (11.28) |
0.52 (22.77) |
3.76 (22.97) |
2.53 (7.62) |
|
|
Stomach |
IMRT |
0.11 (9.76) |
0.13 (7.22) |
0.12 (8.82) |
0.33 (6.04) |
0.49 (5.79) |
| VMAT |
0.44 (9.79) |
0.13 (7.28) |
0.12 (8.82) |
0.33 (6.04) |
0.79 (9.29) |
|
| TOMO |
0.44 (9.79) |
0.13 (7.35) |
0.12 (8.82) |
0.33 (6.04) |
0.38 (4.48) |
|
|
Normal liver |
IMRT |
0.17(6.59) |
0.17 (3.76) |
0.18 (5.62) |
0.21 (1.42) |
0.52 (1.94) |
| VMAT |
0.44 (6.60) |
0.17 (3.75) |
0.18 (5.64) |
0.22 (1.48) |
0.53 (2.00) |
|
| TOMO |
0.46 (6.95) |
0.20 (4.46) |
0.19 (5.95) |
0.23 (1.56) |
0.27 (1.00) |
|
|
Small intestine |
IMRT |
0.27 (5.16) |
0.12 (1.47) |
0.38 (6.08) |
0.72 (4.82) |
0.20 (0.85) |
| VMAT |
0.33 (4.85) |
0.13 (1.65) |
0.38 (6.20) |
0.72 (4.80) |
0.28 (1.22) |
|
| TOMO |
0.37 (5.35) |
0.10 (1.20) |
0.38 (6.05) |
1.24 (8.31) |
0.27 (0.71) |
|
|
Prostate/Ovary |
IMRT |
0.02 (0.07) |
0.01 (0.03) |
0.02 (0.06) |
0.18 (0.61) |
0.07 (0.14) |
| VMAT |
0.10 (0.05) |
0.01 (0.01) |
0.02 (0.06) |
0.15 (0.49) |
0.06 (0.13) |
|
| TOMO |
0.11 (0.06) |
0.01 (0.01) |
0.02 (0.05) |
0.14 (0.46) |
0.05 (0.11) |
|
| Rectum | IMRT |
0.07 (1.36) |
0.04 (0.44) |
0.09 (1.49) |
0.18 (1.20) |
0.06 (0.25) |
| VMAT |
0.08 (1.12) |
0.03 (0.35) |
0.08 (1.26) |
0.14 (0.96) |
0.06 (0.26) |
|
| TOMO | 0.09 (1.32) | 0.03 (0.36) | 0.07 (1.13) | 0.14 (0.95) | 0.05 (0.20) | |
* EAR: per whole prescribed dose.